Filing Details
- Accession Number:
- 0001225208-13-011137
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-02 20:47:46
- Reporting Period:
- 2013-04-30
- Filing Date:
- 2013-05-02
- Accepted Time:
- 2013-05-02 20:47:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1489393 | Lyondellbasell Industries N.v. | LYB | Industrial Organic Chemicals (2860) | 980646235 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1500649 | Massimo Covezzi | Stationsplein 45 3013 Ak P7 | Svp Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares | Acquisiton | 2013-04-30 | 47,991 | $13.11 | 134,301 | No | 4 | M | Direct | |
| Class A Ordinary Shares | Disposition | 2013-04-30 | 1,185 | $60.70 | 133,116 | No | 4 | F | Direct | |
| Class A Ordinary Shares | Disposition | 2013-04-30 | 47,991 | $60.81 | 85,125 | No | 4 | S | Direct | |
| Class A Ordinary Shares | Disposition | 2013-05-01 | 1,257 | $60.55 | 83,868 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares | Opt - Stock Option | Disposition | 2013-04-30 | 47,991 | $0.00 | 47,991 | $13.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 47,991 | 2020-04-30 | No | 4 | M | Direct |
Footnotes
- The exercise of stock options and sale of the shares acquired upon exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in February 2013.
- Includes 83,868 restricted stock units granted pursuant to the issuer's long-term incentive plan: 81,426 granted on April 30, 2010 that vest on April 30, 2015 and 2,442 granted on December 11, 2012 that vest on April 30, 2014.
- This transaction was executed in multiple trades at prices ranging from $60.52 to $61.45. The price reported above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The sale of the shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in February 2013.
- The option was originally granted on April 30, 2010 and vests in three equal installments on the 2nd, 3rd and 4th anniversaries of the date of grant.
Billionaire Hedge Funds
